FindTrial
Sign In

Study of factors (including genetic factors) influencing the levels of tacrolimus in blood before and after intake in renal transplant patients

Population pharmacokinetics and pharmacogenetics of tacrolimus in renal transplant patients - POPTAC

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2013/08/003871
Enrollment
30
Registered
2013-08-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Renal transplant patients on tacrolimus

Interventions

None listed

Sponsors

Jawaharlal Institute of Post Graduate Medical Education and Research JIPMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects Age 18 to 65 years and of either gender. Post renal transplant patients on treatment with tacrolimus

Exclusion criteria

Exclusion criteria: Subjects on parenteral immunosuppressants

Design outcomes

Primary

MeasureTime frame
pharmacokinetics parameters such as volume of distribution, clearanceTimepoint: predose, 0-2hrs, 2-4hrs, 4-12 hrs post dose—

Secondary

MeasureTime frame
pharmacokinetics parameters such as volume of distribution, clearanceTimepoint: single day—

Countries

India

Contacts

Public ContactDr S Suresh Kumar

JIPMER

sureskums@gmail.com919043865754

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026